US Gives Full Approval To Antiviral Drug Remdesivir To Treat COVID-19
World News | Agence France-Presse | Friday October 23, 2020
The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
World News | Reuters | Tuesday October 6, 2020
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
Russia Approves 1st COVID-19 Prescription Drug For Sale In Pharmacies
World News | Reuters | Friday September 18, 2020
Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week, the company said on Friday.
India's Shortage Of Remdesivir Is Easing, Says Producer Cipla
World News | Reuters | Tuesday August 11, 2020
India's supply of antiviral drug remdesivir and generic equivalents is stabilising after shortages of the vital COVID-19 medicine at hospitals, according to a top executive at one of the country's big drugmakers, Cipla Ltd.
Taiwan Provisionally Approves Dexamethasone As Coronavirus Treatment
World News | Reuters | Tuesday August 4, 2020
Taiwan provisionally approved the use of dexamethasone, a cheap and widely-used steroid, to treat the new coronavirus, as the island faces a shortfall of the antiviral drug remdesivir after the United States bought nearly all global supplies.
Central Drug Agency Warns Of Black Marketing Of COVID-19 Drug Remdesivir
India News | Edited by Chandrashekar Srinivasan | Wednesday July 8, 2020
The Drug Controller General of India (DGCI) has raised concerns over black marketing and profiteering of Remdesivir, an antiviral drug prescribed for treatment of suspected or severe lab-confirmed cases of COVID-19.
No Game Changers: Medical Experts On Remdesiver, Favipiravir For COVID Treatment
India News | Press Trust of India | Tuesday June 23, 2020
With pharmaceutical companies launching generic versions of Remdesivir and Favipiravir for COVID-19 treatment, medical experts on Monday said it was a "positive development" in the fight against the pandemic, but cautioned against regarding the antiviral drugs as "game changers".
Glenmark Launches COVID-19 Drug Favipiravir At Rs 103 Per Tablet
India News | Press Trust of India | Sunday June 21, 2020
As Glenmark Pharmaceuticals launched antiviral drug Favipiravir for the treatment of mild to moderate COVID-19 cases, medical experts on Saturday cautioned against seeing it as a "magic bullet" to treat the deadly virus but said it will be helpful as it can be orally administered and reduce viral load.
Zydus Cadila Signs Pact With Gilead To Make Remdesivir
Business | Reuters | Friday June 12, 2020
Antiviral drug remdesivir was the first treatment to show improvement in COVID-19 trials.
Gilead's Drug Prevents Lung Damage In COVID-19 Study On Monkeys: Report
World News | Reuters | Wednesday June 10, 2020
Gilead Sciences Inc's antiviral drug, remdesivir, prevented lung disease in macaque monkeys infected with the new coronavirus, a study published in medical journal Nature showed on Tuesday.
India Approves Emergency Use Of Remdesivir To Treat COVID-19 Patients
India News | Reuters | Tuesday June 2, 2020
The government said on Tuesday it has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating COVID-19 patients.
Gilead's Remdesivir Shows Fair Improvement In Moderate COVID-19 Patients
World News | Reuters | Tuesday June 2, 2020
Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who received the medicine for 10 days in the study did not fare as well.
Coronavirus Cases In India Inch Closer To 63,000-Mark, 2,109 Deaths: 10 Points
India News | Edited by Swati Bhasin | Sunday May 10, 2020
India reported 3,277 new coronavirus patients in the last 24 hours and 128 deaths linked to the illness that brings the total number of cases in the country to 62,939, including 2,109 deaths, the Union Health Ministry said today. At least 50 per cent of these cases have been reported from five major cities - Delhi, Mumbai and Pune in Maharashtra, A...
Strides Pharma Surrenders Early Gains To End Lower On News Of Developing Antivirals For Covid-19
Business | Edited by Peter Noronha | Thursday April 30, 2020
Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.
What New Data Say About Gilead's Experimental Coronavirus Drug
World News | Reuters | Thursday April 30, 2020
New clinical data on Gilead Sciences Inc's experimental antiviral drug remdesivir has raised hopes it might be an effective treatment for the novel coronavirus that has infected more than 3 million people and killed over 225,000 worldwide.
US Gives Full Approval To Antiviral Drug Remdesivir To Treat COVID-19
World News | Agence France-Presse | Friday October 23, 2020
The US Food and Drug Administration on Thursday granted full approval to the antiviral drug remdesivir as a treatment for patients hospitalized with Covid-19, after conditional authorization was given in May.
HIV Treatment Has No Benefit For Hospitalised COVID-19 Patients: Study
World News | Reuters | Tuesday October 6, 2020
A combination of antiviral drugs usually used to treat HIV has no beneficial effect in patients hospitalised with COVID-19, a peer-reviewed study said on Monday, confirming the initial results of a large-scale randomised trial of the drug.
Russia Approves 1st COVID-19 Prescription Drug For Sale In Pharmacies
World News | Reuters | Friday September 18, 2020
Russia has approved R-Pharm's Coronavir treatment for outpatients with mild to moderate COVID-19 infections and the antiviral drug could be rolled out to pharmacies in the country as soon as next week, the company said on Friday.
India's Shortage Of Remdesivir Is Easing, Says Producer Cipla
World News | Reuters | Tuesday August 11, 2020
India's supply of antiviral drug remdesivir and generic equivalents is stabilising after shortages of the vital COVID-19 medicine at hospitals, according to a top executive at one of the country's big drugmakers, Cipla Ltd.
Taiwan Provisionally Approves Dexamethasone As Coronavirus Treatment
World News | Reuters | Tuesday August 4, 2020
Taiwan provisionally approved the use of dexamethasone, a cheap and widely-used steroid, to treat the new coronavirus, as the island faces a shortfall of the antiviral drug remdesivir after the United States bought nearly all global supplies.
Central Drug Agency Warns Of Black Marketing Of COVID-19 Drug Remdesivir
India News | Edited by Chandrashekar Srinivasan | Wednesday July 8, 2020
The Drug Controller General of India (DGCI) has raised concerns over black marketing and profiteering of Remdesivir, an antiviral drug prescribed for treatment of suspected or severe lab-confirmed cases of COVID-19.
No Game Changers: Medical Experts On Remdesiver, Favipiravir For COVID Treatment
India News | Press Trust of India | Tuesday June 23, 2020
With pharmaceutical companies launching generic versions of Remdesivir and Favipiravir for COVID-19 treatment, medical experts on Monday said it was a "positive development" in the fight against the pandemic, but cautioned against regarding the antiviral drugs as "game changers".
Glenmark Launches COVID-19 Drug Favipiravir At Rs 103 Per Tablet
India News | Press Trust of India | Sunday June 21, 2020
As Glenmark Pharmaceuticals launched antiviral drug Favipiravir for the treatment of mild to moderate COVID-19 cases, medical experts on Saturday cautioned against seeing it as a "magic bullet" to treat the deadly virus but said it will be helpful as it can be orally administered and reduce viral load.
Zydus Cadila Signs Pact With Gilead To Make Remdesivir
Business | Reuters | Friday June 12, 2020
Antiviral drug remdesivir was the first treatment to show improvement in COVID-19 trials.
Gilead's Drug Prevents Lung Damage In COVID-19 Study On Monkeys: Report
World News | Reuters | Wednesday June 10, 2020
Gilead Sciences Inc's antiviral drug, remdesivir, prevented lung disease in macaque monkeys infected with the new coronavirus, a study published in medical journal Nature showed on Tuesday.
India Approves Emergency Use Of Remdesivir To Treat COVID-19 Patients
India News | Reuters | Tuesday June 2, 2020
The government said on Tuesday it has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use in treating COVID-19 patients.
Gilead's Remdesivir Shows Fair Improvement In Moderate COVID-19 Patients
World News | Reuters | Tuesday June 2, 2020
Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who received the medicine for 10 days in the study did not fare as well.
Coronavirus Cases In India Inch Closer To 63,000-Mark, 2,109 Deaths: 10 Points
India News | Edited by Swati Bhasin | Sunday May 10, 2020
India reported 3,277 new coronavirus patients in the last 24 hours and 128 deaths linked to the illness that brings the total number of cases in the country to 62,939, including 2,109 deaths, the Union Health Ministry said today. At least 50 per cent of these cases have been reported from five major cities - Delhi, Mumbai and Pune in Maharashtra, A...
Strides Pharma Surrenders Early Gains To End Lower On News Of Developing Antivirals For Covid-19
Business | Edited by Peter Noronha | Thursday April 30, 2020
Strides Pharma shares zoomed more than 10 per cent on the BSE on Thursday after the company said that it has developedFavipiravir antiviral tablets for the treatment of COVID-19.
What New Data Say About Gilead's Experimental Coronavirus Drug
World News | Reuters | Thursday April 30, 2020
New clinical data on Gilead Sciences Inc's experimental antiviral drug remdesivir has raised hopes it might be an effective treatment for the novel coronavirus that has infected more than 3 million people and killed over 225,000 worldwide.
................................ Advertisement ................................
................................ Advertisement ................................
